Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bayerische Patentallianz (BayPAT) is the central technology transfer agency for the Bavarian universities and universities of applied sciences. Established in 2007, the company acts as a specialized service provider for the evaluation, protection, and commercialization of academic inventions. Its primary focus lies in the life sciences, encompassing biotechnology, pharmaceuticals, and medical technology, alongside physical sciences. BayPAT bridges the gap between academic research and industrial application by licensing patented technologies to established companies and supporting the creation of innovative spin-offs. The organization manages an extensive portfolio of intellectual property originating from over 25,000 scientists across Bavaria. By providing professional IP management and marketing services, BayPAT facilitates the translation of high-level scientific discoveries into marketable products and therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bayerische Patentallianz.